Press releases

To stay up to date with our development, sign up for a subscription.


Sedana Medical’s nomination committee appointed


Sedana Medical AB (publ) today publish that in accordance with the resolution of the Annual General Meeting on May 19, 2017, the Chairman of the Board has contacted the company’s three largest shareholders or group of shareholders in terms of votes t…

Sedana Medical AB (publ) recruits Chief Medical Officer


Sedana Medical AB (publ), developing and marketing the medical device AnaConda and volatile anesthetics for sedation of mechanically ventilated intensive care unit (ICU) patients, announced the recruitment of Peter Sackey, MD, PhD as Chief Medical Of…

Sedana Medical AB (publ) recruits new Nordic Sales Manager


Sedana Medical AB (“Sedana Medical” or “the Company”) is recruiting Thor Sundsvik as its Nordic Sales Manager and is thus established in the Nordic region with its own sales organization. Thor Sundsvik joins from Linde Healthcare and will take up his…

Exercise of the overallotment option


Pareto Securities has notified Sedana Medical AB (publ) (”Sedana Medical” or the ”Company”), that the overallotment option has been exercised in full.

Sedana Medical AB (publ) launches AnaConDa-S


Sedana Medical AB (publ) ("Sedana Medical" or "the Company") is launching AnaConDa-S, a new innovation and an enhancement of its predecessor AnaConDa, in which the ‘dead volume’ has been halved from 100 ml to 50 ml. Halving the dead volume increases…

Sedana Medical AB (publ) registers AnaConDa in South Korea


Sedana Medical AB’s (publ) (“Sedana Medical” or " the Company") product AnaConDa is approved by K-FDA in South Korea. South Korea is the first country in Asia to approve AnaConDa. The product will be launched in cooperation with the distributor DaeSe…